MetaADEDB 2.0 @ LMMD
Oxandrolone
(QSLJIVKCVHQPLV-PEMPUTJUSA-N)
Structure
SMILES
O=C1OC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)O)C)C
Type(s)
Approved; Investigational
ATC code(s)
A14AA08
Molecular Formula:
C19H30O3
Molecular Weight:
306.440
Log P:
3.5431
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
53-39-4
Synonym(s)
1.
Oxandrolone
2.
Anavar
3.
Oxandrin
4.
SC-11585
5.
SC 11585
6.
SC11585
External Link(s)
MeSHD010074
PubChem Compound5878
ChEBI7820
CHEMBLCHEMBL1200436
DrugBankDB00621
DrugCentral2011
IUPHAR/BPS Guide to PHARMACOLOGY7092
KEGGcpd:C07346
dr:D00462
Therapeutic Target DatabaseD0U3GL
ZINC3813047
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DehydrationFAERS: 8OFFSIDES
US FAERS
2VomitingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
3NauseaFAERS: 5OFFSIDES
US FAERS
4Abdominal PainFAERS: 3US FAERS
5Drug toxicityFAERS: 3OFFSIDES
US FAERS
6FatigueFAERS: 3US FAERS
7PainFAERS: 3US FAERS
8AstheniaFAERS: 2OFFSIDES
US FAERS
9Back PainFAERS: 2US FAERS
10Biliary dilatationFAERS: 2OFFSIDES
US FAERS
11CellulitisFAERS: 2OFFSIDES
US FAERS
12HeadacheFAERS: 2US FAERS
13Malignant neoplasm progressionFAERS: 2US FAERS
14Platelet count abnormalFAERS: 2OFFSIDES
US FAERS
15Refusal of treatment by relativeFAERS: 2OFFSIDES
US FAERS
16ThrombosisFAERS: 2US FAERS
17Weight decreasedFAERS: 2US FAERS
18AnorexiaFAERS: 1US FAERS
19AscitesFAERS: 1OFFSIDES
US FAERS
20Blood albumin decreasedFAERS: 1US FAERS
21Blood creatinine increasedFAERS: 1OFFSIDES
SIDER
US FAERS
22Blood potassium decreasedFAERS: 1US FAERS
23Blood urea increasedFAERS: 1US FAERS
24Cerebrovascular accidentFAERS: 1US FAERS
25CholestasisFAERS: 1US FAERS
26ConstipationFAERS: 1US FAERS
27DementiaFAERS: 1US FAERS
28Diabetes MellitusFAERS: 1US FAERS
29Disease ProgressionFAERS: 1OFFSIDES
US FAERS
30DysphasiaFAERS: 1US FAERS
31DysuriaFAERS: 1OFFSIDES
US FAERS
32EosinophiliaFAERS: 1US FAERS
33Epigastric discomfortFAERS: 1US FAERS
34ErythemaFAERS: 1US FAERS
35Facial wastingFAERS: 1OFFSIDES
US FAERS
36Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
37Failure to ThriveFAERS: 1US FAERS
38Febrile NeutropeniaFAERS: 1OFFSIDES
US FAERS
39Hepatic InfarctionFAERS: 1US FAERS
40HepatotoxicityFAERS: 1US FAERS
41InfectionFAERS: 1OFFSIDES
US FAERS
42Lobar PneumoniaFAERS: 1US FAERS
43NeutropeniaFAERS: 1US FAERS
44PneumobiliaFAERS: 1US FAERS
45PneumoniaFAERS: 1US FAERS
46PneumothoraxFAERS: 1US FAERS
47Post procedural complicationFAERS: 1US FAERS
48Product counterfeitFAERS: 1US FAERS
49TachycardiaFAERS: 1US FAERS
50TremorFAERS: 1US FAERS
51Urinary RetentionFAERS: 1US FAERS
52Urinary tract infectionFAERS: 1US FAERS
53White blood cell count abnormalFAERS: 1OFFSIDES
US FAERS
54jaundiceFAERS: 1US FAERS
55AcneSIDER
56Activities of daily living impairedOFFSIDES
57AdenocarcinomaOFFSIDES
58Altered bowel functionOFFSIDES
59AlveolitisOFFSIDES
60AmnesiaOFFSIDES
61Androgenetic AlopeciaSIDER
62AnhidrosisOFFSIDES
63AzoospermiaSIDER
64Blood GlucoseOFFSIDES
65Blood testosterone decreasedOFFSIDES
66Blood urine presentOFFSIDES
67Brain natriuretic peptide increasedOFFSIDES
68Bronchial HyperreactivitySIDER
69BruxismOFFSIDES
70COPD exacerbationSIDER
71Creatinine increasedSIDER
72EpididymitisSIDER
73EpistaxisOFFSIDES
74Erectile dysfunction17961146CTD
OFFSIDES
SIDER
75Esophageal and Gastric Varices2099434CTD
76Gastrointestinal ulcerOFFSIDES
77GlomerulonephritisOFFSIDES
78HIV Wasting Syndrome17961146CTD
79Hepatic necrosisSIDER
80HirsutismSIDER
81HistoplasmosisOFFSIDES
82Hypogonadism17961146CTD
83Impaired driving abilityOFFSIDES
84Injection site massOFFSIDES
85Kidney FailureOFFSIDES
86Leukopenia neonatalOFFSIDES
87LipaseOFFSIDES
88Liver AbscessOFFSIDES
89MeningiomaOFFSIDES
90Mental disorders10665271CTD
91Mental status changesOFFSIDES
92Mood disorder due to a general medical conditionOFFSIDES
93Nail InfectionOFFSIDES
94NecrosisSIDER
95OligospermiaSIDER
96OliguriaOFFSIDES
97Peliosis HepatisSIDER
98PemphigusOFFSIDES
99Peptic Ulcer5569832CTD
100Perirectal abscessOFFSIDES
101Porphyrins urine increasedOFFSIDES
102Portal hypertensive gastropathyOFFSIDES
103Postoperative thrombosisOFFSIDES
104PriapismSIDER
105Productive CoughOFFSIDES
106Purulent dischargeOFFSIDES
107Rebound effectOFFSIDES
108Renal tubular necrosisOFFSIDES
109Seizures5569832CTD
110Sex hormone binding globulin decreasedOFFSIDES
111Stent occlusionOFFSIDES
112TinnitusOFFSIDES
113Unresponsive to stimuliOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.